| Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling A Kramer, FC Yang, P Snodgrass, X Li, TE Scammell, FC Davis, CJ Weitz Science 294 (5551), 2511-2515, 2001 | 644 | 2001 |
| Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models H Inoue, L Lin, X Lee, Z Shao, S Mendes, P Snodgrass-Belt, H Sweigard, ... Proceedings of the National Academy of Sciences 104 (36), 14430-14435, 2007 | 203 | 2007 |
| Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7 RT Bartus, PJ Elliott, RL Dean, NJ Hayward, TL Nagle, MR Huff, ... Experimental neurology 142 (1), 14-28, 1996 | 165 | 1996 |
| CHF5074, a novel γ‐secretase modulator, attenuates brain β‐amyloid pathology and learning deficit in a mouse model of Alzheimer's disease BP Imbimbo, B Hutter‐Paier, G Villetti, F Facchinetti, V Cenacchi, R Volta, ... British journal of pharmacology 156 (6), 982-993, 2009 | 103 | 2009 |
| Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters P Snodgrass-Belt, JL Gilbert, FC Davis Brain research 1038 (2), 171-182, 2005 | 81 | 2005 |
| Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters DF Emerich, P Snodgrass, R Dean, M Agostino, B Hasler, M Pink, ... British journal of cancer 80 (7), 964-970, 1999 | 75 | 1999 |
| EC144 is a potent inhibitor of the heat shock protein 90 J Shi, R Van de Water, K Hong, RB Lamer, KW Weichert, CM Sandoval, ... Journal of medicinal chemistry 55 (17), 7786-7795, 2012 | 73 | 2012 |
| Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport™(RMP-7) DF Emerich, P Snodgrass, M Pink, F Bloom, RT Bartus Brain research 801 (1-2), 259-266, 1998 | 65 | 1998 |
| Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain DF Emerich, RL Dean, JA Marsh, M Pink, D Lafreniere, P Snodgrass, ... Pharmaceutical research 17, 1212-1219, 2000 | 61 | 2000 |
| Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions DF Emerich, P Snodgrass, D Lafreniere, RL Dean, H Salzberg, J Marsh, ... Pharmaceutical research 19, 1052-1060, 2002 | 57 | 2002 |
| Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival RT Bartus, P Snodgrass, J Marsh, M Agostino, A Perkins, DF Emerich Journal of Pharmacology and Experimental Therapeutics 293 (3), 903-911, 2000 | 55 | 2000 |
| A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease RT Bartus, D Emerich, P Snodgrass-Belt, K Fu, H Salzberg-Brenhouse, ... Journal of Pharmacology and Experimental Therapeutics 310 (2), 828-835, 2004 | 54 | 2004 |
| Bradykinin modulation of tumor vasculature: II. activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology … DF Emerich, RL Dean, P Snodgrass, D Lafreniere, M Agostino, T Wiens, ... Journal of Pharmacology and Experimental Therapeutics 296 (2), 632-641, 2001 | 53 | 2001 |
| Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors DF Emerich, SR Winn, Y Hu, J Marsh, P Snodgrass, D LaFreniere, ... Pharmaceutical research 17, 767-775, 2000 | 52 | 2000 |
| Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors DF Emerich, SR Winn, P Snodgrass, D LaFreniere, M Agostino, T Wiens, ... Pharmaceutical research 17, 776-781, 2000 | 52 | 2000 |
| Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy DF Emerich, P Snodgrass, RL Dean, D Lafreniere, M Agostino, T Wiens, ... Journal of Pharmacology and Experimental Therapeutics 296 (2), 623-631, 2001 | 42 | 2001 |
| Discovery of BIIB042, a potent, selective, and orally bioavailable γ-secretase modulator H Peng, T Talreja, Z Xin, JH Cuervo, G Kumaravel, MJ Humora, L Xu, ... ACS Medicinal Chemistry Letters 2 (10), 786-791, 2011 | 25 | 2011 |
| Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalling A Kramer, FC Yang, P Snodgrass, X Li, TE Scammell, FC Davis, CJ Weitz Molecular Clocks and Light Signalling: Novartis Foundation Symposium 253 …, 2003 | 24 | 2003 |
| Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies RT Bartus, P Snodgrass, RL Dean, JH Kordower, DF Emerich Experimental Neurology 161 (1), 234-244, 2000 | 21 | 2000 |
| Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach Z Xin, H Peng, A Zhang, T Talreja, G Kumaravel, L Xu, E Rohde, M Jung, ... Bioorganic & medicinal chemistry letters 21 (24), 7277-7280, 2011 | 19 | 2011 |
